HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A J Marian Selected Research

Atherosclerosis

8/2012The enigma of genetics etiology of atherosclerosis in the post-GWAS era.
10/2009Candidate genetic analysis of plasma high-density lipoprotein-cholesterol and severity of coronary atherosclerosis.
11/2002Effects of SREBF-1a and SCAP polymorphisms on plasma levels of lipids, severity, progression and regression of coronary atherosclerosis and response to therapy with fluvastatin.
3/2000A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A J Marian Research Topics

Disease

11Coronary Artery Disease (Coronary Atherosclerosis)
08/2012 - 01/2000
10Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
08/2005 - 03/2000
5Cardiomegaly (Heart Hypertrophy)
08/2005 - 12/2000
5Fibrosis (Cirrhosis)
12/2004 - 02/2001
4Myocardial Infarction
08/2014 - 01/2000
4Atherosclerosis
08/2012 - 03/2000
4Hypertrophy
08/2005 - 04/2001
3Acute Coronary Syndrome
02/2011 - 08/2004
3Heart Failure
07/2006 - 07/2001
2Inflammation (Inflammations)
10/2007 - 01/2000
2Cardiovascular Diseases (Cardiovascular Disease)
08/2005 - 11/2004
2Cardiac Sudden Death (Sudden Cardiac Arrest)
05/2002 - 02/2001
1Ventricular Tachycardia
08/2014
1Ventricular Fibrillation
08/2014
1Neoplasms (Cancer)
01/2014
1Cardiomyopathies (Cardiomyopathy)
01/2014
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2013
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
12/2011
1Familial Thoracic 1 Aortic Aneurysm
10/2007
1Patent Ductus Arteriosus
10/2007
1Wolff-Parkinson-White Syndrome (Wolf-Parkinson-White Syndrome)
01/2005
1Atrioventricular Nodal Reentry Tachycardia (AV Nodal Reentrant Tachycardia)
01/2005
1Heart Diseases (Heart Disease)
11/2004
1Familial Hypertrophic Cardiomyopathy (Cardiomyopathy, Familial Hypertrophic)
01/2002
1Inborn Genetic Diseases (Disease, Hereditary)
10/2001
1Tangier Disease
05/2001
1Hypercholesterolemia
11/2000
1Body Weight (Weight, Body)
03/2000
1Coronary Occlusion
01/2000
1Infections
01/2000

Drug/Important Bio-Agent (IBA)

9Lipoproteins (Lipoprotein)IBA
10/2009 - 01/2000
8Proteins (Proteins, Gene)FDA Link
01/2014 - 03/2000
7LipidsIBA
01/2004 - 01/2000
7FluvastatinFDA Link
11/2002 - 01/2000
4EnzymesIBA
05/2002 - 01/2000
3Phosphotransferases (Kinase)IBA
01/2014 - 12/2001
3Ventricular MyosinsIBA
08/2005 - 07/2001
3Troponin T (Troponin T1)IBA
03/2004 - 02/2001
2Enoxaparin (Lovenox)FDA LinkGeneric
02/2011 - 08/2004
2Biomarkers (Surrogate Marker)IBA
02/2011 - 11/2004
2Heparin (Liquaemin)FDA LinkGeneric
02/2011 - 08/2004
2Apolipoprotein A-I (Apolipoprotein A1)IBA
10/2009 - 05/2001
2HDL CholesterolIBA
10/2009 - 05/2001
2Angiotensin IIIBA
10/2007 - 02/2001
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2007 - 01/2000
2Mitochondrial DNA (mtDNA)IBA
08/2005 - 05/2002
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
08/2005 - 03/2000
2AMP-Activated Protein KinasesIBA
01/2005 - 05/2002
2TroponinIBA
12/2004 - 03/2000
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2004 - 11/2000
2Interleukin-6 (Interleukin 6)IBA
12/2000 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2000 - 01/2000
1Lidocaine (Xylocaine)FDA LinkGeneric
08/2014
1Protein Kinases (Protein Kinase)IBA
01/2014
1PlakophilinsIBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
05/2013
1Biological ProductsIBA
08/2012
1MicroRNAs (MicroRNA)IBA
08/2012
1gamma Catenin (Plakoglobin)IBA
12/2011
1Hemostatics (Antihemorrhagics)IBA
02/2011
11,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
10/2007
1Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
10/2007
1beta Adrenergic ReceptorsIBA
07/2006
1Lipid PeroxidesIBA
08/2005
1Atorvastatin (Lipitor)FDA Link
08/2005
1Biotin (Vitamin H)FDA Link
08/2005
1Glycoproteins (Glycoprotein)IBA
08/2004
1AldosteroneIBA
03/2004
1Spironolactone (Aldactone)FDA LinkGeneric
03/2004
1PPAR alphaIBA
01/2004
1Phosphodiesterase I (5' Exonuclease)IBA
01/2004
1Ion Channels (Ion Channel)IBA
10/2001
1Cytoskeletal ProteinsIBA
10/2001
1Simvastatin (Zocor)FDA LinkGeneric
07/2001
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
05/2001
1Aryldialkylphosphatase (Paraoxonase)IBA
02/2001
1CollagenIBA
02/2001
1Transforming Growth Factor beta1 (TGF beta 1)IBA
02/2001
1Losartan (Cozaar)FDA LinkGeneric
02/2001
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
12/2000
1Transforming Growth Factor beta (TGF-beta)IBA
12/2000
1Insulin (Novolin)FDA Link
12/2000
1ApolipoproteinsIBA
11/2000
1Apolipoproteins E (ApoE)IBA
11/2000
1Tyrosine (L-Tyrosine)FDA Link
03/2000
1NADPH Oxidases (NAD(P)H oxidase)IBA
03/2000
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2000
14- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
03/2000
1Histidine (L-Histidine)FDA Link
03/2000
1Lipoprotein(a)IBA
01/2000
1Genetic Markers (Genetic Marker)IBA
01/2000

Therapy/Procedure

6Therapeutics
11/2004 - 01/2000
1Drug Therapy (Chemotherapy)
11/2000